$385.40
13.07%
NYSE, Nov 18, 03:59 pm EST. Closed.
Why the stock moved Why the stock moved
ISIN
US4448591028
Symbol
HUM

Humana Stock price

$385.78
-29.20 7.04% 1M
+79.78 26.07% 6M
+129.65 50.62% YTD
+151.68 64.79% 1Y
-116.01 23.12% 3Y
-60.19 13.50% 5Y
+185.62 92.74% 10Y
+333.07 631.89% 20Y
NYSE, Closing price Wed, Nov 18 2026
-57.56 12.98%

AI Insights on Humana Insights AI Insights on Humana

How does the company make money?
Who are the company’s main competitors?
What are the key opportunities and risks?
How is the company managed?

Is Humana a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 9,085 stocks worldwide.

Key metrics

Basic
Market capitalization
$46.3b
Enterprise Value
$51.9b
Net debt
$5.6b
Cash
$6.9b
Shares outstanding
120.1m
Valuation
P/E
37.7
P/S | estimate
0.3 | 0.3
EV/Sales | estimate
0.3 | 0.3
EV/FCF | ex SBC
16.5 | 17.8
P/B
2.5
Dividends
DPS
$3.54
Yield 1Y | 5Y
0.9% | 0.9%
Growth 1Y | 5Y
0.0% | 4.8%
Payout 1Y | 3Y
36.0% | 26.7%
Increased
0 Years
Financials
Revenue | estimate
$154.2b | $164.0b
EBITDA
$3.6b
EBIT
$2.9b
Net Income
$1.2b
Free Cash Flow | ex SBC
$3.1b | $2.9b
Growth
Revenue | estimate
22.0% | 26.5%
EBITDA
-14.7%
EBIT
-15.0%
Net Income
-3.5%
Free Cash Flow
102.9%
Margin
Gross
-
EBITDA
2.3%
EBIT
1.9%
Net
0.8%
Free Cash Flow | ex SBC
2.0% | 1.9%
Financial Health
Equity Ratio
36.1%
Return on Equity
6.7%
ROCE
6.3%
ROIC
5.5%
Debt/Equity
0.7
Share-Based Compensation & Dilution
SBC | % of Revenue
$231.0m | 0.1%
SBC as % of FCF
7.4%
SBC Growth 1Y
-6.5%
Share Count Growth 1Y
-0.1%
Shareholder Yield
1.1%
More
EPS
$10.2
FCF per Share
$26.1
Short interest
2.6%
Employees
67k
Rev per Employee
$1.9m

Humana Stock Analysis

Unlock Scores for Free

Analyst Opinions

32 Analysts have issued a Humana forecast:

19x Buy
59%
12x Hold
38%
1x Sell
3%

Analyst Opinions

32 Analysts have issued a Humana forecast:

Buy
59%
Hold
38%
Sell
3%

Humana Events

Past Events
NOV
6
Q3 2026 Earnings Call
13 days ago
JUL
29
Q2 2026 Earnings Call
4 months ago
APR
29
Q1 2026 Earnings Call
7 months ago
MAR
10
Leerink Global Healthcare Conference 2026
8 months ago
FEB
11
Q4 2025 Earnings Call
9 months ago
NOV
19
7th Annual Wolfe Research Healthcare Conference
12 months ago
NOV
5
Q3 2025 Earnings Call
about one year ago

Financial data from Humana

Sep '26
+/-
%
154,209 154,209
22% 22%
100%
- Policy Benefits 134,122 134,122
25% 25%
87%
20,087 20,087
6% 6%
13%
- SG&A - -
-
-
- Other operating expenses 16,509 16,509
12% 12%
11%
3,578 3,578
15% 15%
2%
- Depreciation and Amortization 644 644
13% 13%
0%
2,934 2,934
15% 15%
2%
- Interest Expense 753 753
16% 16%
0%
- Tax Expense 424 424
50% 50%
0%
Net Profit 1,246 1,246
3% 3%
1%

In millions USD.

Don't miss a Thing! We will send you all news about Humana directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Humana Stock News

Neutral
Business Wire
●
2 days ago
LOUISVILLE, Ky.--(BUSINESS WIRE)--The Humana Foundation, the philanthropic arm of Humana Inc. (NYSE: HUM), today announced $13.93 million in fall 2026 grants advancing nutrition security, emotional health, research, and Louisville community initiatives. This month, the Humana Foundation celebrates 45 years of working alongside community partners to help people build healthier, more connected li...
Neutral
Business Wire
●
2 days ago
LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM) today announced the launch of its national Gold Card program on December 1, a key milestone in the company's ongoing public commitment to reduce the need for prior authorization, simplify the process when it is required, reduce paperwork for providers, and help patients access care more quickly. The program will recognize providers who h...
Neutral
Business Wire
●
2 days ago
LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM) (“Humana”, “we”, or “our”) today announced the expiration and final results of its previously announced cash tender offers (collectively, the “Offers”) to purchase the outstanding 2.150% Senior Notes due February 3, 2032 (the “February 2032 Notes”), 3.125% Senior Notes due August 15, 2029 (the “August 2029 Notes”), 3.700% Senior Notes du...
More Humana News

Company Profile

Humana Inc. engages in the provision of health insurance services. The firm operates through the following segments: Retail, Group and Specialty and Healthcare Services.. The Retail segment consists of products sold on a retail basis to individuals including medical and supplemental benefit plans such as Medicare, and State-based Medicaid contracts. The Group and Specialty segment contains employer group fully-insured commercial medical products and specialty health insurance benefits marketed to individuals and groups, including dental, vision, military services and other supplemental health & voluntary insurance benefits. The Healthcare Services segment offer services such as pharmacy solutions, provider services, clinical care, predictive modeling and informatics services to other Humana businesses, as well as external health plan members, external health plans, and other employers. The company was founded by David A. Jones, Sr. and Wendell Cherry in 1961 and is headquartered in Louisville, KY.

Head office United States
CEO Mr. Rechtin
Employees 67,060
Founded 1961
Website www.humana.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today